Epilepsy Pharmacotherapy

H
Heena ParveenPROFESSOR à MRCP
Epilepsy Pharmacotherapy
Epilepsy
An assortment of different seizure types & syndromes
originating from several mechanisms that have
common sudden, excessive & synchronous discharge of
cerebral neurons resulting in loss of
consiousness,abnormal movements, odd behaviour
/distorted perceptions.
Introduction
Seizures occurs when there’s a sudden change in communication of
braincells through electrical signal.
During seizures,some brain cells send abnormal signals which stop
other cells from working perfectly leading to temporary changes n
Behaviour,Sensation,Movement/Consciousness.
Onset---- During childhood & after 65 years of age.
Most seizures are Benign which lasts for longtime called Status
Epilepticus ,a life threatening disease characterised by Continuous
seizures, sustained loss of consiousness, Respiratory distress.
Epidemiology
• Epilepsy does impact on an individual's human rights, for
example, access to health and life insurance is affected.
• A person who suffers from epilepsy may not be able to
obtain a driving licence and it has an impact on the choice
of career.
• Epilepsy is a chronic neurological disorder that affects
people of all ages.
Around 50 million people worldwide have epilepsy.
Nearly 90% of the people with epilepsy are found in
developing regions.
Epilepsy responds to treatment 70% of the time. Despite
this, approximately 75% of affected people in developing
countries do not get the treatment they need.
People with epilepsy and their families suffer from stigma
and discrimination in many parts of the world.
Etiology
Pathogenesis of Epilepsy
There are multiple mechanisms that might contribute to
synchronous hyperexcitability, including:
1) alterations in the distribution, number, type, and biophysical
properties of ion channels in the neuronal membranes;
(2) biochemical modifications of receptors;
(3) modulation of second messaging systems and gene
expression;
(4) changes in extracellular ion concentrations;
(5) alterations in neurotransmitter uptake and metabolism in
glial cells; and
(6) modifications in the ratio and function of inhibitory circuits.
Transitory imbalances between the main neurotransmitters, glutamate
(excitatory) and γ -aminobutyric-acid (GABA) (inhibitory),&
neuromodulators (e.g., acetylcholine, norepinephrine,and
serotonin) might play a role in precipitating seizures in susceptible
patients.
Epilepsy Pharmacotherapy
• Diagnosing epilepsy can be difficult as it is first
necessary to demonstrate a tendency to recurrent
episodes of epilepsy.
There are other conditions that may cause impairment or loss of consciousness
and which can be misdiagnosed as epilepsy; these include
syncope,
breath-holding attacks,
transient ischaemic attacks,
psychogenic attacks, etc.
Other problems such as metabolic dysfunction,
infection,
head trauma
or flashing lights (photosensitive seizures).
These conditions have to be clearly ruled out before a diagnosis of epilepsy is
made.
• The EEG is often the only examination required,
particularly in generalised epilepsies, and it aims
to record abnormal neuronal discharges.
• Neuroimaging with magnetic resonance imaging
(MRI) is the most valuable investigation when
structural abnormalities such as stroke, tumour,
congenital abnormalities or hydrochephalus are
suspected. MRI should be carried out in anyone
presenting with partial seizures or where a
structural lesion on the brain may be responsible
for seizures.
Neuro-imaging techniques such as:
MRI,PET,SPECT.
Abnormal electrcal activity during a seizure can be detected
by EEG.
Seizures have been categorized by site of origin, etiology,
electrophysiologc correlation ,clinical presentation.
Seizures have been classified in to2 broad groups:
• Partial (Simple & Complex)
• Generalized(Tonic-Clonic & Absence).
• Others (Myoclonic, Febrile, Status epilepticus).
Epilepsy Pharmacotherapy
Epilepsy Pharmacotherapy
Epilepsy Pharmacotherapy
Epilepsy Pharmacotherapy
Epilepsy Pharmacotherapy
• Absence seizures:
These involve brief, abrupt, self-limiting loss of
consiousness.
In 3-5 years of age patients(onset occurs) & lasts
till puberty.
Patient stops speaking in mid-sentence, & stares vacantly for
few seconds(3-5sec).
Epilepsy Pharmacotherapy
Febrile seizures
Young children may develop with illness accompanied by
high fever.
Intermittent muscle spasm & progressive metal
deterioration.
Epilepsy Pharmacotherapy
Epilepsy Pharmacotherapy
ANTI -EPILEPTICS
These are the drugs used in the treatment of EPILEPSY.
Barbiturates : Phenobarbitone.
Deoxybarbiturate : Primidone.
Hydantoin : Phenytoin,Fosphenytoin.
Immunostilbines : Carbamazepine,Carbazepine.
Succimide : Ethosuximide.
Aliphatic carboxylic acids: Sodium valproate, Divalproate.
Phenylriazine : Lamotrigine.
Cyclic GABA analogue : Gabapentin.
Newer drugs :Vigabatrine, Tiagabine,Topiramate,
Levetiractem.
BZD’s : Diazepam,Lorazepam,Oxazepam,
Clonazepam.
Mechanism of Action
The 3 mechanisms appear to be
important action of Epilepsy.
I. Enhancement of GABA action.
II. Inhibition of Na+2 channel function.
III. Inhibition of Ca+2 channel function.
IV. Inhibition of Glutamate release & Blockade of
receptors.
Epilepsy Pharmacotherapy
Enhancement of GABA action:( BZD’s, Barbiturates)
Vigabatrin -- Inhibits enzyme“GABATransaminase”.
Tiagabine --Inhibits GABAuptake & enhance action of
GABA.
Gabapetin – designed as an agonist @ GABAA Receptors.
Inhibition of Na+2 channel function:
(Phenyltriazine,Hydantoins,Immunostibines,
Aliphatic –COOH’s).
These drugs affect membrane excitabilty by an action on voltage-
gated Na+2 channels, which carry the inward membrane current
necessary for generation of Action potential.
Inhibition of Ca+2 channels: (Suucimides,Gabapetin).
Succimides blocks T-type Ca+2 channels .
Gabapentin blocks L-type Ca+2 channels .
Pharmacokinetics:
Absorption ----Slow on oral administration.
Bioavailability differs in market preparations.
Distribution is wide & 80-90% bound to plasma proteins.
Metabolism– Liver by Hydroyxlation & Glucoronide
conjugation.
T1/2– 12-24hrs & increases up to 60 hrs.
Only 5%Unchanged Phenytoin is excreted in urine.
Adverse Effects:
@ Therapeutic levels— Due to over growth of
Collagen fibres causes Gum Hypertrophy.(Can b minimized by
Oral hygiene).
Girls- Hirsutism,Acne,Coarsening of facial features.
Hypersensitivity Reactions-Rashes,Lymphadenopathy,Neutropenia.
Megaloblastic AnaemiaIt decreases Folate absorption &
increases folate excretion.
Osteomalacia, Hypergycemia, In pregnancy—causes
FOETAL HYDANTOIN SYNDROME.
@ Higher levels– Cerebellar & Vestibular
manifestations: Ataxia, Vertigo, Diplopia,
Nystagmus. Drowsiness,Mental confuion,
Hallucinations, Disorientation, Muscle rigidity.
Epigastric pain, Nausea & vomiting
(Can b minimized when taken with meals).
I.V injection causes Local injury, oedema, vein
thrombosis, Discolouration of injected
limb,Hypotension & Cardiac arrhythmias.
Carbamazepine + Phenytoin creases each others Metabolism.
Isoniazid, Cimetidine, Dicumerol,Warfarin  Inhibits Phenytoin
metabolsim.
Phenytoin induces Steroid degradation.
Sodium Valproate Decreases metabolism & Increases Phenyton
plasma levels.
USES
1st line Anti-Epileptic for Generalized Tonic-Clonic
,Simple &Complex partial seizures.
In Status Epilepticus.
In Trigeminal Neuralgia.
Epilepsy Pharmacotherapy
1 sur 33

Recommandé

Epilespy pharmacotherapy par
Epilespy pharmacotherapyEpilespy pharmacotherapy
Epilespy pharmacotherapysara_abudahab
6.3K vues134 diapositives
Pharmacotherapy of Parkinson’s disease par
Pharmacotherapy of Parkinson’s diseasePharmacotherapy of Parkinson’s disease
Pharmacotherapy of Parkinson’s diseaseMayur Chaudhari
3.2K vues53 diapositives
Antiparkinsonian Drugs par
Antiparkinsonian DrugsAntiparkinsonian Drugs
Antiparkinsonian DrugsEneutron
1.8K vues33 diapositives
Elimination enhancement par
Elimination enhancementElimination enhancement
Elimination enhancementvelspharmd
16.4K vues26 diapositives
General principles involved in management of poisoning (Part 1) par
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)RxVichuZ
4.1K vues8 diapositives
Pharmacotherapy of schizophrenia par
Pharmacotherapy of schizophreniaPharmacotherapy of schizophrenia
Pharmacotherapy of schizophreniaPrasheeta V P
3.9K vues37 diapositives

Contenu connexe

Tendances

Antiepileptics par
Antiepileptics Antiepileptics
Antiepileptics Naser Tadvi
184.2K vues30 diapositives
Pharmacotherapy of depression par
Pharmacotherapy of depressionPharmacotherapy of depression
Pharmacotherapy of depressionMANISH mohan
2.4K vues76 diapositives
Pharmacotherapy of epilepsy par
Pharmacotherapy of epilepsyPharmacotherapy of epilepsy
Pharmacotherapy of epilepsyDr Swaroop HS
25.3K vues47 diapositives
Pharmacology of Antiepileptic Drugs par
Pharmacology of Antiepileptic DrugsPharmacology of Antiepileptic Drugs
Pharmacology of Antiepileptic Drugsshabeel pn
47.5K vues73 diapositives
Recent Advances in Pharmacotherapy of Migraine par
Recent Advances in Pharmacotherapy of MigraineRecent Advances in Pharmacotherapy of Migraine
Recent Advances in Pharmacotherapy of MigraineHtet Wai Moe
3.5K vues36 diapositives
Pharmacology - Parkinsonism par
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - ParkinsonismMBBS IMS MSU
71.6K vues31 diapositives

Tendances(20)

Antiepileptics par Naser Tadvi
Antiepileptics Antiepileptics
Antiepileptics
Naser Tadvi184.2K vues
Pharmacotherapy of depression par MANISH mohan
Pharmacotherapy of depressionPharmacotherapy of depression
Pharmacotherapy of depression
MANISH mohan2.4K vues
Pharmacotherapy of epilepsy par Dr Swaroop HS
Pharmacotherapy of epilepsyPharmacotherapy of epilepsy
Pharmacotherapy of epilepsy
Dr Swaroop HS25.3K vues
Pharmacology of Antiepileptic Drugs par shabeel pn
Pharmacology of Antiepileptic DrugsPharmacology of Antiepileptic Drugs
Pharmacology of Antiepileptic Drugs
shabeel pn47.5K vues
Recent Advances in Pharmacotherapy of Migraine par Htet Wai Moe
Recent Advances in Pharmacotherapy of MigraineRecent Advances in Pharmacotherapy of Migraine
Recent Advances in Pharmacotherapy of Migraine
Htet Wai Moe3.5K vues
Pharmacology - Parkinsonism par MBBS IMS MSU
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - Parkinsonism
MBBS IMS MSU71.6K vues
Pharmacotherapy of Alzheimer's Disease par Harshad Malve
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's Disease
Harshad Malve17.1K vues
Drug treatment of alzheimers disease par Naser Tadvi
Drug treatment of alzheimers diseaseDrug treatment of alzheimers disease
Drug treatment of alzheimers disease
Naser Tadvi72.8K vues
Classification and mechanism of action of alzheimers drugs par SajalChowdhury4
Classification and mechanism of action of alzheimers drugs Classification and mechanism of action of alzheimers drugs
Classification and mechanism of action of alzheimers drugs
SajalChowdhury42.6K vues
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera... par Soujanya Pharm.D
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Soujanya Pharm.D5.1K vues
General principles involved in management of poisoning- by rxvichu!! par RxVichuZ
General principles involved in management of poisoning- by rxvichu!!General principles involved in management of poisoning- by rxvichu!!
General principles involved in management of poisoning- by rxvichu!!
RxVichuZ 68.1K vues
Parkinsons disease V Pharm.D par Dr.Sohel Memon
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
Dr.Sohel Memon10.2K vues
Chap 1 General principles involved in the management of poisoning par Chanukya Vanam . Dr
Chap 1 General principles involved in the management of poisoningChap 1 General principles involved in the management of poisoning
Chap 1 General principles involved in the management of poisoning
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen par pavithra vinayak
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders par Abel C. Mathew
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Abel C. Mathew10.2K vues

Similaire à Epilepsy Pharmacotherapy

recent advances in antiepileptics par
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepilepticspriyanka527
716 vues47 diapositives
Epilepsy & Antiepileptic Drugs par
Epilepsy & Antiepileptic DrugsEpilepsy & Antiepileptic Drugs
Epilepsy & Antiepileptic DrugsSyed Shayan
2.3K vues28 diapositives
MANAGEMENT OF EPILEPSY par
MANAGEMENT OF EPILEPSYMANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSYsethafrifa
51 vues58 diapositives
Epilepsy par
EpilepsyEpilepsy
EpilepsyDRx Lalit Borse
21 vues17 diapositives
Epilepsy par
EpilepsyEpilepsy
Epilepsyishwarpatil22
16 vues12 diapositives
MANAGEMENT OF EPILEPSY MODIFIED 2.pptx par
MANAGEMENT OF EPILEPSY MODIFIED 2.pptxMANAGEMENT OF EPILEPSY MODIFIED 2.pptx
MANAGEMENT OF EPILEPSY MODIFIED 2.pptxJENNIFERENEKWECHI
11 vues37 diapositives

Similaire à Epilepsy Pharmacotherapy(20)

recent advances in antiepileptics par priyanka527
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepileptics
priyanka527716 vues
Epilepsy & Antiepileptic Drugs par Syed Shayan
Epilepsy & Antiepileptic DrugsEpilepsy & Antiepileptic Drugs
Epilepsy & Antiepileptic Drugs
Syed Shayan2.3K vues
MANAGEMENT OF EPILEPSY par sethafrifa
MANAGEMENT OF EPILEPSYMANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSY
sethafrifa51 vues
4_2019_01_09!10_21_48_PM.ppt par Thuyamani M
4_2019_01_09!10_21_48_PM.ppt4_2019_01_09!10_21_48_PM.ppt
4_2019_01_09!10_21_48_PM.ppt
Thuyamani M2 vues
Epilepsy: Diagnostics, Medications, Myths and Facts par abdul waheed
Epilepsy: Diagnostics, Medications, Myths and FactsEpilepsy: Diagnostics, Medications, Myths and Facts
Epilepsy: Diagnostics, Medications, Myths and Facts
abdul waheed9.9K vues
Status epilepticus sign and symptoms, etiology ,pathogenesis , diagnostic te... par Jaindokhanlashari
Status epilepticus  sign and symptoms, etiology ,pathogenesis , diagnostic te...Status epilepticus  sign and symptoms, etiology ,pathogenesis , diagnostic te...
Status epilepticus sign and symptoms, etiology ,pathogenesis , diagnostic te...
Presentation on Epilepsy and Its Animal Models par Gagandeep Jaiswal
Presentation on Epilepsy and Its Animal ModelsPresentation on Epilepsy and Its Animal Models
Presentation on Epilepsy and Its Animal Models

Plus de Heena Parveen

NSAID'S --ASPIRIN par
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRINHeena Parveen
15.2K vues18 diapositives
NSAID'S par
NSAID'SNSAID'S
NSAID'SHeena Parveen
136 vues10 diapositives
Bioassay of Digitalis, d-tubocurarine , Oxytocin par
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinHeena Parveen
10.7K vues26 diapositives
Bioassay of insulin & Bioassay of Vasopressin par
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinHeena Parveen
9.1K vues15 diapositives
Bioassay ,its types for theory & practical par
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalHeena Parveen
2.5K vues21 diapositives
Neuromuscular blockers &; skeletal muscle relaxants par
Neuromuscular blockers &; skeletal muscle relaxantsNeuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxantsHeena Parveen
792 vues30 diapositives

Plus de Heena Parveen(20)

Bioassay of Digitalis, d-tubocurarine , Oxytocin par Heena Parveen
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Heena Parveen10.7K vues
Bioassay of insulin & Bioassay of Vasopressin par Heena Parveen
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of Vasopressin
Heena Parveen9.1K vues
Bioassay ,its types for theory & practical par Heena Parveen
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practical
Heena Parveen2.5K vues
Neuromuscular blockers &; skeletal muscle relaxants par Heena Parveen
Neuromuscular blockers &; skeletal muscle relaxantsNeuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxants
Heena Parveen792 vues
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICS par Heena Parveen
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICSSympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Heena Parveen1.8K vues
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester... par Heena Parveen
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Heena Parveen529 vues
NEUROTRANSMITTERS & RECEPTORS IN ANS par Heena Parveen
NEUROTRANSMITTERS & RECEPTORS IN ANS NEUROTRANSMITTERS & RECEPTORS IN ANS
NEUROTRANSMITTERS & RECEPTORS IN ANS
Heena Parveen584 vues
NEUROHUMORAL TRANSMISSION par Heena Parveen
NEUROHUMORAL TRANSMISSIONNEUROHUMORAL TRANSMISSION
NEUROHUMORAL TRANSMISSION
Heena Parveen18.4K vues
ORGANSATION & FUNCTIONS OF ANS par Heena Parveen
ORGANSATION & FUNCTIONS OF ANSORGANSATION & FUNCTIONS OF ANS
ORGANSATION & FUNCTIONS OF ANS
Heena Parveen6.5K vues
FACTORS MODIFYING DRUG ACTION par Heena Parveen
FACTORS MODIFYING DRUG ACTIONFACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTION
Heena Parveen295 vues
Types of receptor signal transduction pathways par Heena Parveen
Types of receptor signal transduction pathwaysTypes of receptor signal transduction pathways
Types of receptor signal transduction pathways
Heena Parveen332 vues
Drug discovery & clinical evaluation of new drugs par Heena Parveen
Drug discovery & clinical evaluation of new drugsDrug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugs
Heena Parveen4.5K vues
Pharmacokinetics absorption,distribution,metabolism,excretion par Heena Parveen
Pharmacokinetics  absorption,distribution,metabolism,excretionPharmacokinetics  absorption,distribution,metabolism,excretion
Pharmacokinetics absorption,distribution,metabolism,excretion
Heena Parveen1.1K vues

Dernier

corticosteroids.pptx par
corticosteroids.pptxcorticosteroids.pptx
corticosteroids.pptxRAJ K. MAURYA
51 vues26 diapositives
Spermatogenesis presentation.ppsx par
Spermatogenesis presentation.ppsxSpermatogenesis presentation.ppsx
Spermatogenesis presentation.ppsxNeerajVishwakarma54
6 vues24 diapositives
definition of Femoroacetabular impingement.pptx par
definition of Femoroacetabular impingement.pptxdefinition of Femoroacetabular impingement.pptx
definition of Femoroacetabular impingement.pptxHome
6 vues15 diapositives
Diagnosis of tumor.ppt par
Diagnosis of tumor.pptDiagnosis of tumor.ppt
Diagnosis of tumor.pptSekaran T
6 vues32 diapositives
NMP-9.pptx par
NMP-9.pptxNMP-9.pptx
NMP-9.pptxSai Sailesh Kumar Goothy
28 vues46 diapositives
Pulmonary Embolism for Nurses.pptx par
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptxAsraf Hussain
33 vues31 diapositives

Dernier(20)

definition of Femoroacetabular impingement.pptx par Home
definition of Femoroacetabular impingement.pptxdefinition of Femoroacetabular impingement.pptx
definition of Femoroacetabular impingement.pptx
Home6 vues
Diagnosis of tumor.ppt par Sekaran T
Diagnosis of tumor.pptDiagnosis of tumor.ppt
Diagnosis of tumor.ppt
Sekaran T6 vues
Pulmonary Embolism for Nurses.pptx par Asraf Hussain
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptx
Asraf Hussain33 vues
Structural Racism and Public Health: How to Talk to Policymakers and Communit... par katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley331.1K vues
Explore new Frontiers in Medicine with AI.pdf par Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie12 vues
Complications & Solutions in Laparoscopic Hernia Surgery.pptx par Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9129 vues
eTEP -RS Dr.TVR.pptx par Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9142 vues
3rd lecture PCR-Presentation.ppt par gayubshah
3rd lecture PCR-Presentation.ppt3rd lecture PCR-Presentation.ppt
3rd lecture PCR-Presentation.ppt
gayubshah6 vues
24th oct Pulp Therapy In Young Permanent Teeth.pptx par ismasajjad1
24th oct Pulp Therapy In Young Permanent Teeth.pptx24th oct Pulp Therapy In Young Permanent Teeth.pptx
24th oct Pulp Therapy In Young Permanent Teeth.pptx
ismasajjad114 vues
PATIENTCOUNSELLING in.pptx par skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi126 vues

Epilepsy Pharmacotherapy

  • 2. Epilepsy An assortment of different seizure types & syndromes originating from several mechanisms that have common sudden, excessive & synchronous discharge of cerebral neurons resulting in loss of consiousness,abnormal movements, odd behaviour /distorted perceptions.
  • 3. Introduction Seizures occurs when there’s a sudden change in communication of braincells through electrical signal. During seizures,some brain cells send abnormal signals which stop other cells from working perfectly leading to temporary changes n Behaviour,Sensation,Movement/Consciousness. Onset---- During childhood & after 65 years of age. Most seizures are Benign which lasts for longtime called Status Epilepticus ,a life threatening disease characterised by Continuous seizures, sustained loss of consiousness, Respiratory distress.
  • 4. Epidemiology • Epilepsy does impact on an individual's human rights, for example, access to health and life insurance is affected. • A person who suffers from epilepsy may not be able to obtain a driving licence and it has an impact on the choice of career. • Epilepsy is a chronic neurological disorder that affects people of all ages. Around 50 million people worldwide have epilepsy. Nearly 90% of the people with epilepsy are found in developing regions. Epilepsy responds to treatment 70% of the time. Despite this, approximately 75% of affected people in developing countries do not get the treatment they need. People with epilepsy and their families suffer from stigma and discrimination in many parts of the world.
  • 7. There are multiple mechanisms that might contribute to synchronous hyperexcitability, including: 1) alterations in the distribution, number, type, and biophysical properties of ion channels in the neuronal membranes; (2) biochemical modifications of receptors; (3) modulation of second messaging systems and gene expression; (4) changes in extracellular ion concentrations; (5) alterations in neurotransmitter uptake and metabolism in glial cells; and (6) modifications in the ratio and function of inhibitory circuits.
  • 8. Transitory imbalances between the main neurotransmitters, glutamate (excitatory) and γ -aminobutyric-acid (GABA) (inhibitory),& neuromodulators (e.g., acetylcholine, norepinephrine,and serotonin) might play a role in precipitating seizures in susceptible patients.
  • 10. • Diagnosing epilepsy can be difficult as it is first necessary to demonstrate a tendency to recurrent episodes of epilepsy. There are other conditions that may cause impairment or loss of consciousness and which can be misdiagnosed as epilepsy; these include syncope, breath-holding attacks, transient ischaemic attacks, psychogenic attacks, etc. Other problems such as metabolic dysfunction, infection, head trauma or flashing lights (photosensitive seizures). These conditions have to be clearly ruled out before a diagnosis of epilepsy is made.
  • 11. • The EEG is often the only examination required, particularly in generalised epilepsies, and it aims to record abnormal neuronal discharges. • Neuroimaging with magnetic resonance imaging (MRI) is the most valuable investigation when structural abnormalities such as stroke, tumour, congenital abnormalities or hydrochephalus are suspected. MRI should be carried out in anyone presenting with partial seizures or where a structural lesion on the brain may be responsible for seizures.
  • 12. Neuro-imaging techniques such as: MRI,PET,SPECT. Abnormal electrcal activity during a seizure can be detected by EEG. Seizures have been categorized by site of origin, etiology, electrophysiologc correlation ,clinical presentation. Seizures have been classified in to2 broad groups: • Partial (Simple & Complex) • Generalized(Tonic-Clonic & Absence). • Others (Myoclonic, Febrile, Status epilepticus).
  • 18. • Absence seizures: These involve brief, abrupt, self-limiting loss of consiousness. In 3-5 years of age patients(onset occurs) & lasts till puberty. Patient stops speaking in mid-sentence, & stares vacantly for few seconds(3-5sec).
  • 20. Febrile seizures Young children may develop with illness accompanied by high fever. Intermittent muscle spasm & progressive metal deterioration.
  • 23. ANTI -EPILEPTICS These are the drugs used in the treatment of EPILEPSY. Barbiturates : Phenobarbitone. Deoxybarbiturate : Primidone. Hydantoin : Phenytoin,Fosphenytoin. Immunostilbines : Carbamazepine,Carbazepine. Succimide : Ethosuximide. Aliphatic carboxylic acids: Sodium valproate, Divalproate. Phenylriazine : Lamotrigine. Cyclic GABA analogue : Gabapentin. Newer drugs :Vigabatrine, Tiagabine,Topiramate, Levetiractem. BZD’s : Diazepam,Lorazepam,Oxazepam, Clonazepam.
  • 25. The 3 mechanisms appear to be important action of Epilepsy. I. Enhancement of GABA action. II. Inhibition of Na+2 channel function. III. Inhibition of Ca+2 channel function. IV. Inhibition of Glutamate release & Blockade of receptors.
  • 27. Enhancement of GABA action:( BZD’s, Barbiturates) Vigabatrin -- Inhibits enzyme“GABATransaminase”. Tiagabine --Inhibits GABAuptake & enhance action of GABA. Gabapetin – designed as an agonist @ GABAA Receptors. Inhibition of Na+2 channel function: (Phenyltriazine,Hydantoins,Immunostibines, Aliphatic –COOH’s). These drugs affect membrane excitabilty by an action on voltage- gated Na+2 channels, which carry the inward membrane current necessary for generation of Action potential. Inhibition of Ca+2 channels: (Suucimides,Gabapetin). Succimides blocks T-type Ca+2 channels . Gabapentin blocks L-type Ca+2 channels .
  • 28. Pharmacokinetics: Absorption ----Slow on oral administration. Bioavailability differs in market preparations. Distribution is wide & 80-90% bound to plasma proteins. Metabolism– Liver by Hydroyxlation & Glucoronide conjugation. T1/2– 12-24hrs & increases up to 60 hrs. Only 5%Unchanged Phenytoin is excreted in urine.
  • 29. Adverse Effects: @ Therapeutic levels— Due to over growth of Collagen fibres causes Gum Hypertrophy.(Can b minimized by Oral hygiene). Girls- Hirsutism,Acne,Coarsening of facial features. Hypersensitivity Reactions-Rashes,Lymphadenopathy,Neutropenia. Megaloblastic AnaemiaIt decreases Folate absorption & increases folate excretion. Osteomalacia, Hypergycemia, In pregnancy—causes FOETAL HYDANTOIN SYNDROME.
  • 30. @ Higher levels– Cerebellar & Vestibular manifestations: Ataxia, Vertigo, Diplopia, Nystagmus. Drowsiness,Mental confuion, Hallucinations, Disorientation, Muscle rigidity. Epigastric pain, Nausea & vomiting (Can b minimized when taken with meals). I.V injection causes Local injury, oedema, vein thrombosis, Discolouration of injected limb,Hypotension & Cardiac arrhythmias.
  • 31. Carbamazepine + Phenytoin creases each others Metabolism. Isoniazid, Cimetidine, Dicumerol,Warfarin  Inhibits Phenytoin metabolsim. Phenytoin induces Steroid degradation. Sodium Valproate Decreases metabolism & Increases Phenyton plasma levels.
  • 32. USES 1st line Anti-Epileptic for Generalized Tonic-Clonic ,Simple &Complex partial seizures. In Status Epilepticus. In Trigeminal Neuralgia.